ETF Battles ARKG vs. GNOM – What’s the better genomic/biotech play?

Are you ready to go to rumble? In this episode of ETF Battles you’ll see a clash between the ARK Genomics Revolution ETF (ARKG) vs. the Global X Genomics & Biotechnology ETF (GNOM). Which ETF is the better play?

Ron DeLegge @ETFguide referees the matchup with guest judges Cinthia Murphy at and Dave Kreinces at ETF Portfolio Management providing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!

ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. If you’re ready for a bold trade, visit

Get in touch with our judges:

ETF Portfolio Management

Get help with your investing habits
Get help building your investment portfolio
Get feedback on your portfolio’s risk
Check your investment performance
60 Smart Ways to Retire Better
Talk with Ron:

1) Spotify

2) iTunes
3) Amazon Music
4) Google Podcasts

#Genomics #ETF #Biotech

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Do You Want To Boost Your Business?

drop us a line and keep in touch